Chronic kidney disease: open trials in France

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Centre Hospitalier Universitaire Amiens Picardie, Amiens Cedex 1 · Centre Hospitalier Universitaire Rouen, Bois-Guillaume · Centre hospitalier Universitaire de Bordeaux, Bordeaux · Assistance Publique Hopitaux De Paris, Boulogne-Billancourt · Centre Hospitalier Régional et Universitaire de Brest, Brest · University Hospital Of Clermont-Ferrand, Clermont Ferrand Cedex 1 · Assistance Publique Hopitaux De Paris, Creteil · Centre Hospitalier Departemental Vendee, La Roche Sur Yon Cedex 9 · Centre Hospitalier Le Mans, Le Mans Cedex 9 · Centre Hospitalier Et Universitaire de Limoges, Limoges · Hospices Civils De Lyon, Lyon Cedex 03 · Centre Hospitalier Regional De Marseille, Marseille · CHRU De Nancy, Nancy Cedex · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 18 · Hospices Civils de Lyon, Pierre-Bénite · Centre Hospitalier Universitaire de Poitiers, Poitiers · Centre Hospitalier Intercommunal De Cornouaille, Quimper Cedex · Centre Hospitalier Universitaire Reims, Reims · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Hôpital Privé Nord Parisien, Sarcelles · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex · Centre Hospitalier Régional Universitaire de Tours, Tours

  Registry updated 2026-11-06

• NCT07604922

  Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

  Trial Treatment · Institut National de la Santé Et de la Recherche Médicale, France

  INSERM U970, Equipe 7, 56 rue Leblanc, Paris

  Registry updated 2026-11-06

• NCT07241390

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Centre Hospitalier Universitaire Rouen, Bois-Guillaume · Chu Gabriel Montpied, Clermont-Ferrand · Chu Grenoble Alpes, La Tronche · Centre Hospitalier Louis Pasteur, Le Coudray · Hospital Edouard Herriot, Lyon · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse · Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes · Centre Hospitalier Universitaire de Nice - Hopital Pasteur, Nice · Hopitaux Universitaires Pitie Salpetriere, Paris · Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9 · Centre Hospitalier Regional Universitaire De Tours, Tours Cedex 9 · CHRU De Nancy, Vandoeuvre Les Nancy

  Registry updated 2026-11-04

• NCT06823115

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  Research · Indiana University

  Hôpital des Enfants, Toulouse

  Registry updated 2026-10-28

• NCT07893691

  Microbiota Changes Related to Outcomes in Kidney Transplantation

  Research · Hospices Civils de Lyon

  Service de Transplantation, Néphrologie et Immunologie Clinique, Hôpital Edouard Herriot, Lyon

  Registry updated 2026-10-26

• NCT02938611

  Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

  Research · Centre Hospitalier Universitaire de Nīmes

  AIDER - Unité de Dialyse d'Alès, Alès · CHU de Nimes - Hopital Universitaire Caremeau, Nîmes · AIDER - Unité de Dialyse de Nîmes, CHU Carémeau, Nîmes · Gardialyse, Nîmes

  Registry updated 2026-10-20

• NCT07141628

  Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease

  Research · Centre Hospitalier Universitaire de Nīmes

  CHU de Nimes - Hopital Universitaire Caremeau, Nîmes

  Registry updated 2026-10-20

• NCT07651436

  Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients

  Trial Treatment · Centre Hospitalier Annecy Genevois

  Centre Hospitalier Annecy Genevois, Annecy · Centre Hospitalier Métropole Savoie, Chambéry

  Registry updated 2026-10-20

• NCT07729358

  Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients

  Trial Treatment · Centre Hospitalier Annecy Genevois

  Centre Hospitalier Annecy Genevois, Annecy

  Registry updated 2026-10-20

• NCT07869849

  A Minute for my Kidneys

  Trial Treatment · GCS Ramsay Santé pour l'Enseignement et la Recherche

  Hôpital Privé La Louviere, Lille

  Registry updated 2026-10-13

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Assistance Publique Hopitaux de Paris, Paris

  Registry updated 2026-10-05

• NCT05287945

  Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  Trial Treatment · Phase 1/2 · Oncorena AB

  Institut de Cancerologie Gustave-Roussy, Villejuif

  Registry updated 2026-10-01

• NCT05457283

  A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

  Trial Treatment · Phase 3 · Bayer

  Centre hospitalier Universitaire de Bordeaux, Bordeaux · Hospices Civils de Lyon, Bron · Centre Hospitalier Universitaire de Montpellier, Montpellier · Assistance Publique Hopitaux de Paris, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-09-24

• NCT07624305

  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  Trial Treatment · Phase 3 · AstraZeneca

  Boulogne-sur-Mer · Caen · Cherbourg · Colmar · La Roche-sur-Yon · Le Mans · Marseille · Nîmes · Orléans · Rouen · Saint-Priez En Jarez · Toulouse · Tours

  Registry updated 2026-09-24

• NCT05485961

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Trial Treatment · Phase 2/3 · CSL Behring

  CHU Amiens - Nephrology Dialysi Transplantation Department, Amiens · CHU de Saint-Étienne - Hôpital Nord, Aura · Centre Hospitalier Regional Universitaire (CHRU) Brest - Hopital de la Cavale Blanche, Brest · CHU de CAEN, Caen · Polyclinique Saint Come - Centre de Dialyse, Compiègne · Fondation Charles Mion AIDER Santé, Grabels · Hôpital Privé La Louviere, Lille · CHU de Limoges, Limoges · Hopitaux Universitaires de Marseille, Marseille · Centre Hospitalier Universitaire Montpellier - Hôpital Lapeyronie, Montpellier · CHE de Nice - Pasteur Hospital, Nice · CHU de Nimes - Hopital Universitaire Caremeau, Nîmes · AURA Paris - Plaisance, Paris · Hopital Pitie-Salpetriere, Paris · Centre Hospitalier Universitaire (CHU) de Reims - Hopital Maison Blanche, Reims · AURA St Quen Dialysis centre, Saint-Ouen · Hopitaux Universitaires de Strasbourg - Hopital Civil, Strasbourg · CHU Rangueil, Toulouse

  Registry updated 2026-09-21

• NCT07444515

  Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients.

  Trial Treatment · Centre Hospitalier Universitaire de la Réunion

  Groupe Hospitalier Est Réunion, Saint-Benoît · CHU Reunion site 1, Saint-Denis · AURAR, Saint-Paul · CHU Reunion site 2, Saint-Pierre

  Registry updated 2026-09-16

• NCT07074418

  Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

  Trial Treatment · Phase 4 · Centre Hospitalier Universitaire de Nice

  CHU Nice - Hôpital Pasteur 2, Nice

  Registry updated 2026-09-10

• NCT07811505

  CXCR2 Leucocyte Expression Level as a Predictive Factor of Coronary Artery Calcification Progression in Advanced Chronic Kidney Disease Patients

  Trial Treatment · Centre Hospitalier Universitaire, Amiens

  CHRU Amiens, Amiens

  Registry updated 2026-09-10

• NCT07753993

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  Trial Treatment · Phase 3 · AstraZeneca

  Centre hospitalier Universitaire de Bordeaux, Bordeaux · Chu Gabriel Montpied, Clermont-Ferrand · Centre Hospitalier Sud Francilien, Corbeil-Essonnes · Centre Hospitalier Annecy Genevois, Epagny Metz-tessy · Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Cedex 9 · Centre Hospitalier Groupe Hospitalier De La Rochelle Re Aunis, La Rochelle · Centre Hospitalier De Laval, Laval · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Centre Hospitalier Du Puy, Le Puy-En-Velay · Centre Hospitalier Saint Joseph Saint Luc, Lyon · Centre Hospitalier Universitaire de Montpellier, Montpellier · Hospital Hotel Dieu, Nantes · Centre Hospitalier Universitaire D Orleans, Orleans Cedex 2 · Hospices Civils de Lyon, Pierre-Bénite · Hôpital NOVO, Pontoise · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9 · Centre Hospitalier de Valenciennes, Valenciennes

  Registry updated 2026-09-09

• NCT03573089

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  Trial Treatment · The University of Queensland

  AURA Paris - Plaisance, Paris

  Registry updated 2026-08-26

• NCT03969329

  A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

  Trial Treatment · Phase 3 · Amgen

  Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron · Hôpital Armand-Trousseau, Paris

  Registry updated 2026-08-21

• NCT05753930

  Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

  Trial Treatment · Phase 2 · Hansa Biopharma AB

  Robert Debre University Hospital, Paris

  Registry updated 2026-08-18

• NCT07763483

  Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?

  Research · Hospices Civils de Lyon

  Hôpital Femme Mère Enfant, Bron

  Registry updated 2026-08-17

• NCT06439862

  Study of the Quality of Life in School Aged-children With Posterior Urethral Valves

  Research · Hospices Civils de Lyon

  Femme-Mère-Enfant Hospital, Bron

  Registry updated 2026-08-05

• NCT06708338

  Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis

  Trial Treatment · Centre Hospitalier Emile Roux

  Centre Hospitalier Emile Roux, Le Puy-en-Velay · Hôpital Saint Joseph Saint Luc, Lyon · Centre Hospitalier de Moulins-Yzeure, Moulins · Ctre Hospitalier Intercommunal Poissy St Germain Site Poissy, Poissy

  Registry updated 2026-08-04

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error